Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

about

Alternative causes of myocardial ischemia in women: An update on spontaneous coronary artery dissection, vasospastic angina and coronary microvascular dysfunction.

P2860

Q38692393-838EA0A3-8AE1-430F-B455-758885C8B833

P2860

Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

Item

http://www.wikidata.org/entity/Q43118454

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

@en

Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

@nl

type

Item

label

Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

@en

Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

@nl

prefLabel

Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

@en

Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

@nl

P1476

Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

@en

P2093

Alison L Bailey

http://www.w3.org/2001/XMLSchema#string

Susan S Smyth

http://www.w3.org/2001/XMLSchema#string

P2860

Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation.

In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the Nation

Relation between C reactive protein concentrations and coronary microvascular endothelial function

Gender differences in artery wall biomechanical properties throughout life.

The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report.

Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study.

C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase.

P304

654-655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1016/J.JCIN.2012.03.014

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22721661

http://www.w3.org/2001/XMLSchema#string

P932

3690140

http://www.w3.org/2001/XMLSchema#string

Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

about

P2860

P2860

Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932